Loading

Zambon Biotech SA

June 04, 2024
Company Presentation
CNS/Neurological
Company Presentation Theater 1
Zambon Biotech SA is a specialized biotech company that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules. Zambon Biotech is part of Zambon, a modern multinational chemical-pharmaceutical company established in 1906. It is committed to innovating cure and care to improve patients’ lives. Zambon employs 2,798 people worldwide, is present in 23 countries in Europe, America and Asia. Thanks to its innovative, quality products commercialized in 87 countries, the group reported a revenue of 900 million euros in 2023. Alongside the three historical therapeutic areas - diseases of the respiratory system, urinary tract infections and pain treatment – Zambon pharma business is focused on developing treatments for neurodegenerative diseases such as Parkinson's or rare diseases such
Zambon Biotech SA
Company Website: http://zambon.com
Lead Product in Development: Phase III in BOS

Company HQ City

Cadempino

Company HQ State

Switzerland

Company HQ Country

Switzerland

CEO/Top Company Official

Frank Weber MD

Development Phase of Primary Product

Multiple Products in Market
Speakers
Cibele Sabido David, PhD
Head of Business Development
Zambon Biotech
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS